Rhys
644 posts






Just spoke to an HHS insider & man, Eli Lilly is going nuts with the peptide wars First of all, as we speak they are pushing the FDA to reclassify the glp-1s as biologics instead of peptides so that: 1. Compounding pharmacies can’t touch them, as they’re not allowed to dispense biologics. Only large manufacturers contracted by big pharma can produce biologics 2. They can extend the patents by 10-15 years min The FDA classifies anything under 40 amino acids a peptide, over 40 a biologic & they’re pushing extremely hard on Retatrutide Retatrutide sits at 39 amino acids, technically a peptide. But the argument they’re pushing is that certain side chains should be counted as amino acids, pushing it over the peptide threshold This strategy has precedent since pharma already used it to push fertility compounds like HCG, FSH & HMG into the biologic classification, removing them from the compounding pathway Patents expire, but the classification system doesn't


Now more than ever, we have to work with our international partners to deliver for Australians back home. I’m in Brunei to help secure our fuel and fertiliser supply, and to keep Australia moving.







Total2 First target hit almost perfectly before this dump. That’s w1 gone. Now for the real fun. Crypto $7 trillion dollar cap. Trump just fkt up the tradfi economy while taking the lead on the only real money game left. #crypto

⚡️Beirut now Holy shit…










